MENU
JDOC
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

JDOC stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Health
JDOC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for JDOC with price predictions
Sep 11, 2026

Momentum Indicator for JDOC turns negative, indicating new downward trend

JDOC saw its Momentum Indicator move below the 0 level on September 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator turned negative. In 36 of the 46 cases, the stock moved further down in the following days. The odds of a decline are at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for JDOC moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In 16 of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.

The Moving Average Convergence Divergence Histogram (MACD) for JDOC turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 27 similar instances when the indicator turned negative. In 18 of the 27 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

JDOC moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JDOC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where JDOC advanced for three days, in 85 of 113 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

JDOC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 135 of 152 cases where JDOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), AstraZeneca PLC (NYSE:AZN), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Bristol-Myers Squibb Co (NYSE:BMY), CVS HEALTH Corp (NYSE:CVS).

Industry description

The investment seeks to provide long-term capital appreciation. The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.

Market Cap

The average market capitalization across the JPMorgan Healthcare Leaders ETF ETF is 98.24B. The market cap for tickers in the group ranges from 1.92B to 994.49B. LLY holds the highest valuation in this group at 994.49B. The lowest valued company is BHVN at 1.92B.

High and low price notable news

The average weekly price growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was -3%. For the same ETF, the average monthly price growth was -3%, and the average quarterly price growth was 9%. ROG experienced the highest price growth at 7%, while COO experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was 19%. For the same stocks of the ETF, the average monthly volume growth was -3% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 50
Price Growth Rating: 44
SMR Rating: 61
Profit Risk Rating: 68
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
JDOC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
J.P. Morgan Exchange-Traded Fund Trust390 Madison AvenueNew York
Phone
(844) 457-6383
Web
jpmorganfunds.com